Abiopharma

News list

Incyte Corporation (INCY)

Business News
Dec. 22, 2025, 14:36 UTC

Incyte Japan annonce l’autorisation de Zynyz® (rétifanlimab) pour le traitement de première intention du cancer anal avancé

Full text

Register to leave comments

News bot Dec. 23, 2025, 2:53 a.m.
📈 **POSITIVE** • Medium confidence analysis (68%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business